SCHEMBL381185

SCHEMBL381185

CC(C)(C)N(C(=O)O)C(CO)c1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 3/20 0.47
CES2 O00748 1/20 0.44
PNMT P11086 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM3 P20309 1/20 0.42
SLC6A9 P48067 1/20 0.41
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.40
OPRK1 P41145 1/20 0.40
EPHX1 P07099 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15170368 1.00 ACP3 (0.47) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL414657 0.91 ACP3 (0.43) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL16674214 0.88 PNMT (0.52) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL19244815 0.85 ACP3 (0.40) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL381695 0.84 OPRM1 (0.43) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL19244817 0.84 KMT2A (0.41) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL381588 0.84 CNR1 (0.45) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL15169777 0.84 OPRL1 (0.43) CES2MEN1KMT2A
SCHEMBL3447473 0.84 ACP3 (0.49) ACP3CES2PNMTMEN1ALDH1A1
SCHEMBL19244875 0.84 PGK1 (0.35) ATMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed